Deep Brain Stimulation for Parkinson's Disease

This trial tests new patterns of Deep Brain Stimulation (DBS) for individuals with Parkinson's disease. Researchers aim to determine if these patterns can be safely and comfortably used at home. The trial includes three different treatment groups: one uses a special biphasic waveform, another applies theta burst stimulation during sleep, and the last employs alternating frequencies in specific brain areas. Individuals who have had stable DBS therapy for at least six months and have Parkinson's confirmed by a specialist might be suitable candidates. As an unphased trial, this study provides a unique opportunity to explore innovative DBS patterns that could improve daily life for Parkinson's patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Biphasic Deep Brain Stimulation (bDBS) is safe and generally well-tolerated. Studies have found no major differences when comparing bDBS to traditional treatments. It has been tested in patients with conditions like dystonia, and most participants have handled it well.

For Nocturnal Theta Burst Stimulation (tDBS), research has examined its effects on Parkinson's disease symptoms. Studies suggest that this type of stimulation might help improve certain functions. While the main focus has been on its effectiveness, safety data does not reveal major concerns.

Region-Specific Frequency Alternation (fDBS) is a newer method. Research is ongoing to determine the best settings for deep brain stimulation in Parkinson's patients. Although detailed safety data is still being collected, the fact that this method is being tested suggests it is reasonably safe, as earlier research phases must demonstrate safety before further testing.

Researchers are excited about these treatments for Parkinson's Disease because they offer innovative approaches to deep brain stimulation (DBS). Unlike traditional DBS, which typically uses constant, unchanging electrical pulses, the Biphasic DBS (bDBS) arm uses a biphasic waveform to ensure charge balancing. The Nocturnal Theta Burst Stimulation (tDBS) arm aligns stimulation with the participant's sleep schedule, potentially enhancing therapeutic effects during nighttime. Lastly, the Region-Specific Frequency Alternation (fDBS) arm provides a customized frequency approach, applying high-frequency stimulation to certain brain regions and low-frequency to others, which could optimize symptom control. These methods aim to improve on current DBS strategies by offering more tailored and potentially more effective therapy options for individuals with Parkinson's Disease.

This trial will compare different types of deep brain stimulation for Parkinson's disease. Research has shown that biphasic deep brain stimulation (bDBS), one of the treatments in this trial, works well and is safe for people with movement disorders like Parkinson's disease. In some studies, patients experienced noticeable improvements in their ability to move. Another treatment option in this trial, nocturnal theta burst stimulation (tDBS), enhanced overall function and quality of life for Parkinson's patients, with some experiencing long-lasting relief from symptoms. Region-specific frequency alternation (fDBS), also being tested in this trial, showed promise in addressing specific issues like tremors and stiffness, offering targeted relief. Each treatment has potential benefits, but results can vary from person to person.¹²⁵⁶⁷